Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study.
Furukawa
S
S
Yasuda
S
S
Amengual
O
O
Horita
T
T
Atsumi
T
T
Koike
T
T
D000328:Adult; D000368:Aged; D000990:Antithrombin III / Q000032:analysis; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D004730:Endothelium, Vascular / Q000378:metabolism*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000032:analysis; D010865:Pilot Projects; D017035:Pravastatin / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000378:metabolism; D014841:von Willebrand Factor / Q000032:analysis
D015415:Biomarkers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; C046193:antithrombin III-protease complex; D014841:von Willebrand Factor; D000990:Antithrombin III; D010447:Peptide Hydrolases; D017035:Pravastatin